Renato Gomes

Renato Gomes serves as a key procurement professional within the National Institute on Drug Abuse (NIDA), supporting the agency’s mission to advance scientific research on substance use disorders through strategic acquisition of high-impact scientific and technical services. He manages a diverse portfolio of research-supporting contracts, primarily focused on analytical instrumentation, laboratory testing, and biological product development, ensuring that NIDA’s funded studies have access to cutting-edge capabilities for neurobiological and behavioral research. His acquisitions are designed to translate laboratory findings into clinical and public health applications, aligning closely with NIDA’s translational research priorities. Gomes maintains strong, ongoing relationships with leading academic research institutions including The McLean Hospital Corporation, the University of Maryland Baltimore, the University of Miami, the University of Pittsburgh, and the Icahn School of Medicine at Mount Sinai. These partnerships reflect a preference for collaboration with high-capacity research entities capable of delivering complex, multi-site scientific services, including clinical trial support, neuroimaging analysis, and biomarker validation. His contracting approach emphasizes institutional expertise and proven research infrastructure over commercial vendor models. His procurement patterns show a strong orientation toward open competition, with approximately 80% of awards issued without set-aside restrictions, reflecting the specialized nature of the scientific work required. The remaining 19.8% are awarded under Total Small Business Set-Asides, demonstrating a measured but consistent commitment to small business participation in support of niche technical services, particularly in laboratory testing and instrument maintenance. His primary NAICS focus areas include 334516 (Analytical Laboratory Instrument Manufacturing) and 541380 (Testing Laboratories and Services), underscoring his expertise in procuring advanced analytical equipment and specialized research services critical to addiction science. He routinely acquires services related to neurochemical analysis, behavioral assay development, and biological product characterization, ensuring NIDA’s research ecosystem remains at the forefront of scientific innovation.